Related Experiment Video

Updated: Aug 8, 2026

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
10:02

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Published on: June 2, 2023

Glucuronoxylomannan exhibits potent immunosuppressive properties

Claudia Monari1, Francesco Bistoni, Anna Vecchiarelli

  • 1Microbiology Section, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Perugia, Italy.

FEMS Yeast Research
|May 16, 2006
PubMed

Insights

Glucuronoxylomannan from Cryptococcus neoformans suppresses the immune system by inducing T cell apoptosis. This fungal polysaccharide is a key virulence factor in life-threatening infections.

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Cryptococcus neoformans is an opportunistic fungal pathogen causing severe infections.
  • Its capsular polysaccharide is a critical virulence factor.
  • Glucuronoxylomannan (GXM) is the major capsular component with known immunosuppressive properties.

Purpose of the Study:

  • To analyze the immunosuppressive effects of glucuronoxylomannan.
  • To investigate the mechanisms by which GXM induces T cell apoptosis.

Main Methods:

  • Literature review focusing on GXM's role in immunosuppression.
  • Analysis of studies detailing GXM interactions with immune cells.

Main Results:

  • Glucuronoxylomannan exhibits potent immunosuppressive effects in vitro and in vivo.
  • GXM actively induces apoptosis in T cells, contributing to immune evasion.

Conclusions:

  • GXM-mediated T cell apoptosis is a significant virulence mechanism for Cryptococcus neoformans.
  • Understanding these mechanisms is crucial for developing therapeutic strategies against cryptococcosis.

More Related Videos

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Xenograft Skin Model to Manipulate Human Immune Responses In Vivo08:23

Xenograft Skin Model to Manipulate Human Immune Responses In Vivo

Published on: June 29, 2022

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview